1. Home
  2. TNGX vs PBFS Comparison

TNGX vs PBFS Comparison

Compare TNGX & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • PBFS
  • Stock Information
  • Founded
  • TNGX 2014
  • PBFS 1889
  • Country
  • TNGX United States
  • PBFS United States
  • Employees
  • TNGX N/A
  • PBFS N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • TNGX Health Care
  • PBFS Finance
  • Exchange
  • TNGX Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • TNGX 317.4M
  • PBFS 309.6M
  • IPO Year
  • TNGX N/A
  • PBFS N/A
  • Fundamental
  • Price
  • TNGX $1.95
  • PBFS $12.00
  • Analyst Decision
  • TNGX Strong Buy
  • PBFS
  • Analyst Count
  • TNGX 7
  • PBFS 0
  • Target Price
  • TNGX $12.33
  • PBFS N/A
  • AVG Volume (30 Days)
  • TNGX 809.1K
  • PBFS 26.3K
  • Earning Date
  • TNGX 05-07-2025
  • PBFS 05-12-2025
  • Dividend Yield
  • TNGX N/A
  • PBFS N/A
  • EPS Growth
  • TNGX N/A
  • PBFS 6.93
  • EPS
  • TNGX N/A
  • PBFS 0.76
  • Revenue
  • TNGX $42,069,000.00
  • PBFS $88,118,000.00
  • Revenue This Year
  • TNGX N/A
  • PBFS N/A
  • Revenue Next Year
  • TNGX N/A
  • PBFS N/A
  • P/E Ratio
  • TNGX N/A
  • PBFS $15.55
  • Revenue Growth
  • TNGX 15.17
  • PBFS 10.09
  • 52 Week Low
  • TNGX $1.72
  • PBFS $8.76
  • 52 Week High
  • TNGX $12.02
  • PBFS $12.20
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.66
  • PBFS 58.29
  • Support Level
  • TNGX $1.80
  • PBFS $11.76
  • Resistance Level
  • TNGX $2.01
  • PBFS $12.20
  • Average True Range (ATR)
  • TNGX 0.21
  • PBFS 0.25
  • MACD
  • TNGX 0.01
  • PBFS -0.01
  • Stochastic Oscillator
  • TNGX 31.94
  • PBFS 66.10

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: